-
Mashup Score: 0Home - 3 hour(s) ago
Tuesday, December 10, 2024 1:30 pm – 2:00 pm ET CME Virtual Dr Haley Ellis will discuss testing for and treating HER2-positive biliary tract cancer (BTC). She will review the latest data for current and emerging HER2-targeted therapies for BTC and use a patient case to highlight important considerations for patient selection and optimal management of side effects associated with newer HER2-targeted therapies. In support of improving patient care, Medscape, LLC is jointly accredited with commendation by
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1NF1-Associated PN Community Insights: Key Questions, Expert Answers - 24 hour(s) ago
This 30-minute live social event features two expert faculty members leading an interactive discussion focused on the care of patients with neurofibromatosis…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
𝐒𝐀𝐕𝐄 𝐓𝐇𝐄 𝐃𝐀𝐓𝐄! LIVE back-to-back discussions on NOVEMBER 26 re: neurofibromatosis type 1-associated plexiform neurofibromas (NF1 PNs). 🟣 12:00p ET: Key Qs, Expert As https://t.co/17WBt7WlOz 🔵 1:00p ET: Improve Patient/Clinician Reality https://t.co/7Gk4e8jEfo https://t.co/H09sJeQUvB
-
-
Mashup Score: 1Home - 1 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🩺 Master therapeutic approaches for DLBCL across lines of therapy. 💡 Build confidence in personalizing treatment using the latest clinical evidence to optimize patient outcomes. 🔬https://t.co/wD2qSJfN7N #DLBCL #Hematology https://t.co/bljNIe4EfC
-
-
Mashup Score: 1Home - 1 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf
-
-
Mashup Score: 1Home - 2 day(s) ago
Tuesday, December 10, 2024 1:30 pm – 2:00 pm ET CME Virtual Dr Haley Ellis will discuss testing for and treating HER2-positive biliary tract cancer (BTC). She will review the latest data for current and emerging HER2-targeted therapies for BTC and use a patient case to highlight important considerations for patient selection and optimal management of side effects associated with newer HER2-targeted therapies. In support of improving patient care, Medscape, LLC is jointly accredited with commendation by
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Expand your knowledge on HER2 testing in BTC. 💡 Gain confidence in selecting HER2-targeted therapies, managing side effects, and staying updated on precision medicine advancements. 🌟 Optimize patient care: https://t.co/iMdyMFVgJY #BTC #PrecisionMedicine https://t.co/OZtpSDAs8b
-
-
Mashup Score: 0Home - 3 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, Oncologists1Tweet-
🔬 THIS WEEK! Explore the latest clinical data on therapies targeting IDH mutations in gliomas. 💡 Build confidence in identifying patients & integrating novel treatments within your multidisciplinary team. 👉 Register now: https://t.co/DlXGkV6jaM #Glioma #TargetedTherapies https://t.co/gsBFRQAdIr
-
-
Mashup Score: 1Home - 3 day(s) ago
Wednesday, November 20, 2024 2:30 PM – 3:00 PM EST CME Virtual Join us for a livestream virtual webinar exploring the intricacies in care for patients with unresectable hepatocellular carcinoma (HCC). This 30-minute event will feature Drs. Lipika Goyal and Tim Greten who will discuss strategies for utilizing first-line immunotherapy in advanced unresectable HCC and highlight considerations in treatment selection and evidence-based management. Participants will have the opportunity to engage with faculty
Source: events.medscapelive.orgCategories: General Medicine News, Oncologists1Tweet-
📚 Boost your knowledge on immunotherapy for frontline treatment of advanced unresectable HCC. 💡 Gain confidence in choosing the right strategies & understanding combo benefits. 🔗 Learn more: https://t.co/31qzIZ7zY2 https://t.co/UdKNmiNzW3
-
-
Mashup Score: 1Home - 3 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🩺 Master therapeutic approaches for DLBCL across lines of therapy. 💡 Build confidence in personalizing treatment using the latest clinical evidence to optimize patient outcomes. 🔬https://t.co/wD2qSJfN7N #DLBCL #Hematology https://t.co/bljNIe4EfC
-
-
Mashup Score: 0Gene Therapies for Hemophilia A and Hemophilia B at #ASH24 - 5 day(s) ago
Explore groundbreaking gene therapies for Hemophilia A and B at #ASH24. Join leading experts for insights into the latest advancements, treatment strategies, and research updates in gene therapy. Stay at the forefront of hemophilia care with cutting-edge discussions and developments.
Source: events.medscapelive.orgCategories: General Medicine News, Oncologists1Tweet-
🧬 Uncover the latest on gene therapies for hemophilia at #ASH24! 🩺 Get insights into clinical differences, refine patient monitoring, and confidently guide treatment decisions. 🔍 Discover more: https://t.co/11UDu3om9S https://t.co/QeeBOzdTCX
-
-
Mashup Score: 1Home - 8 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf
-
🔬 Expand your knowledge on HER2 testing in BTC. 💡 Gain confidence in selecting HER2-targeted therapies, managing side effects, and staying updated on precision medicine advancements. 🌟 Optimize patient care: https://t.co/iMdyMFVgJY #BTC #PrecisionMedicine https://t.co/OZtpSDAs8b